SBUX
45
2
BXP
38
4
WYNN
37
3
GM
44
4
GRMN
48
2
TXN
35
3
PWR
54
3
NAVI
30
6
PSX
50
6
TMO
47
4
SIG
54
2
VRSN
53
4
NI
73
3
ADBE
44
4
PYPL
33
8
HBAN
60
9
GOOGL
45
2
KMB
48
-2
CLX
68
2
AVGO
54
2
SBUX
45
2
BXP
38
4
WYNN
37
3
GM
44
4
GRMN
48
2
TXN
35
3
PWR
54
3
NAVI
30
6
PSX
50
6
TMO
47
4
SIG
54
2
VRSN
53
4
NI
73
3
ADBE
44
4
PYPL
33
8
HBAN
60
9
GOOGL
45
2
KMB
48
-2
CLX
68
2
AVGO
54
2
Financhill
Back

NeuroPace Stock Price Chart

Economy going through a "period of transition" - Your portfolio doesn't have to

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32

NPCE
NeuroPace

Last Price:
$11.28
Seasonality Move:
-26.29%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NPCE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NeuroPace Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 11.03 Sell
20-day SMA: 12.21 Sell
50-day SMA: 12.57 Sell
200-day SMA: 8.95 Buy
8-day EMA: 11.1 Sell
20-day EMA: 11.88 Sell
50-day EMA: 12.02 Sell
200-day EMA: 10.27 Buy

NeuroPace Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.61 Sell
Relative Strength Index (14 RSI): 39.73 Sell
Chaikin Money Flow: 48288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.23 - 13.57) Sell
Bollinger Bands (100): (8.33 - 13.27) Sell

NeuroPace Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for NeuroPace Stock

Is NeuroPace Stock a Buy?

  • NeuroPace share price is 10.74 while NPCE 8-day simple moving average is 11.03, which is a Sell signal.
  • The stock price of NPCE is 10.74 while NeuroPace 20-day SMA is 12.21, which makes it a Sell.
  • NeuroPace 50-day simple moving average is 12.57 while NPCE share price is 10.74, making it a Sell technically.
  • NPCE stock price is 10.74 and NeuroPace 200-day simple moving average is 8.95, creating a Buy signal.

NPCE Technical Analysis vs Fundamental Analysis

Sell
32
NeuroPace (NPCE) is a Sell

Is NeuroPace a Buy or a Sell?

  • NeuroPace stock is rated a Sell
    The current NeuroPace [NPCE] share price is $10.74. The Score for NPCE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.

NeuroPace Stock Info

Market Cap:
349.6M
Price in USD:
10.74
Share Volume:
97.8K

NeuroPace 52-Week Range

52-Week High:
15.77
52-Week Low:
5.45
Sell
32
NeuroPace (NPCE) is a Sell

NeuroPace Share Price Forecast

  • What is the NeuroPace stock price today?
    The NeuroPace stock price is 10.74 USD today.
  • Will NPCE stock go up or go down?
    NeuroPace> share price is forecast to RISE/FALL based on technical indicators
  • Is NeuroPace overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, NeuroPace is overvalued.

Is NeuroPace Stock a Buy?

  • NeuroPace share price is 10.74 while NPCE 8-day exponential moving average is 11.10, which is a Sell signal.
  • The stock price of NPCE is 10.74 while NeuroPace 20-day EMA is 11.88, which makes it a Sell.
  • NeuroPace 50-day exponential moving average is 12.02 while NPCE share price is 10.74, making it a Sell technically.
  • NPCE stock price is 10.74 and NeuroPace 200-day simple moving average is 10.27, creating a Buy signal.

Fundamental Analysis of NeuroPace

Is NeuroPace a good investment?

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.05 per share, an increase this year of $0.14 per share, and an increase next year of $0.15 per share.

Technical Analysis of NeuroPace

Should I short NeuroPace stock?

  • NPCE Moving Average Covergence Divergence (MACD) indicator is -0.61, suggesting NeuroPace is a Sell
  • NeuroPace Relative Strength Index (RSI) is 39.73, which suggest NeuroPace is oversold
  • The Bollinger Bands (25) for NeuroPace is (11.23 - 13.57), which suggest NeuroPace is a Sell
  • The Bollinger Bands (100) for NeuroPace is (8.33 - 13.27), which suggest NeuroPace is a Sell

* NeuroPace stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.